CONSTITUENT REPORT
Lindestrene
Lindestrene is a myrrh-associated furanosesquiterpene best understood in the AromaForge archive as a resin-oil identity marker rather than a well-characterized standalone wellness constituent. Live sources support its chemical identity, repeated occurrence in myrrh volatile fractions, and its contribution to characteristic myrrh aroma, but the direct constituent-specific literature is thin. A small number of papers connect lindestrene-containing volatile fractions with coccidicidal or analgesic context, yet the evidence is not strong enough to present lindestrene itself as an established active; this record should stay conservative and chemistry-led.
Chemical identity and composition
PubChem identifies lindestrene as C15H18O with InChIKey BZQURGSQMBBPRU-DZGCQCFKSA-N. In the archive it appears in myrrh profiles near 10% to 11%, consistent with published myrrh literature that places lindestrene among the major furanosesquiterpene markers of Commiphora myrrha volatile extracts.
Aroma and practical use
- Use the recorded balsamic, camphor-like, musty, incense-like, camphoraceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
myrrh volatile composition
A 2005 myrrh composition paper reported lindestrene among the major volatiles, including 12.9% in the supercritical CO2 extract, supporting its status as a meaningful myrrh marker constituent.
Measured: major volatile constituents and relative abundance
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
avian coccidiosis context
A 2011 laboratory study tested volatile oils including lindestrene against avian coccidial oocysts and reported reduced oocyst survival, but the evidence is still application-specific and not a human-use or isolated-constituent efficacy claim.
Measured: reduction in living unsporulated and sporulated oocysts
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
No dedicated constituent-specific human safety assessment for isolated lindestrene was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Current safety interpretation is therefore inferred mainly from myrrh-oil context rather than a direct lindestrene toxicology dossier.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Because the evidence base is thin, archive copy should avoid presenting lindestrene as either unusually risky or unusually beneficial without stronger direct data.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
CurzereneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Curzerene report →Furanoeudesma-1,3-dieneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Furanoeudesma-1,3-diene report →How the effects were investigated
aroma contribution in myrrh
A modern myrrh review states that myrrh's characteristic balsamic odor is linked to furanosesquiterpenes, with furanoeudesma-1,3-diene and lindestrene specifically highlighted as aroma-defining constituents.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (7)
- No verified human clinical literature specific to isolated lindestrene was found in this pass.
- Direct toxicology and dermal-sensitization data for isolated lindestrene remain sparse in public sources.
- Most functional claims around lindestrene come from myrrh mixtures or volatile fractions rather than clean single-constituent experiments.
- No IFRA standard, Tisserand & Young dermal maximum, or peer-reviewed dermal-limit/phototoxicity study specific to isolated lindestrene (CAS 2221-88-7) was located in this pass; whole-myrrh sensitization concerns exist in the literature, but the specific reactive compounds identified (oxo-furanogermacranes, alismol) do not clearly include lindestrene, so dermal_limit_pct, sensitizing, and phototoxic were reset to null rather than treated as verified.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.